BioWorld by Clarivate Explores the Future of CAR T Therapy in Mainland China in Special Report
Clarivate(CLVT) Prnewswire·2024-04-30 07:00Three-part report investigates rapid pipeline growth, partnerships, clinical trials, and patient access challenges in cancer treatment LONDON, April 30, 2024 /PRNewswire/ -- BioWorld™ published by Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, explores the growing investment in CAR T therapy development in mainland China in a new series titled "China's CAR T market comes of age." The report examines the dynamic realm of CAR T-cell therapies in China, including the rapi ...